An opinion piece in the NY Times earlier this month questioned the extremely long time that the FDA is taking to approve GM animals. The article considered the 17 years that have passed since AquaBounty applied for approval for its GM salmon from FDA (this process has not yet been concluded), and suggested that the FDA should ensure other promising genetically modified animals don’t meet the same end. The article pointed out that every application needs to be painstakingly evaluated, and not every modified animal should be approved, but it also pointed out that in cases like AquaBounty’s product, where all the available evidence indicates that the animals are safe, political calculations or unfounded fears should not keep these products off the market.  Read more